Outset Medical (OM) Inks Multi-Year Deal to Boost Home Dialysis
https://www.zacks.com/stock/news/2257983/outset-medical-om-inks-multi-year-deal-to-boost-home-dialysis?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2257983
Apr 18, 2024 - Outset Medical's (OM) latest agreement is likely to provide patients and caregivers access to innovative home dialysis with the Tablo Hemodialysis System.
0
Reasons Why You Should Retain Masimo (MASI) Stock for Now
https://www.zacks.com/stock/news/2258633/reasons-why-you-should-retain-masimo-masi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2258633
Apr 19, 2024 - Masimo's (MASI) R&D activities raise optimism about the stock.
0
CVRx's (CVRX) Latest Data Favors Barostim's Long-Term Benefits
https://www.zacks.com/stock/news/2258579/cvrx-s-cvrx-latest-data-favors-barostim-s-long-term-benefits?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2258579
Apr 19, 2024 - CVRx's (CVRX) announcement of the availability of additional data supporting the long-term benefits of Barostim is likely to lead to improved patient care.
0
GE HealthCare's (GEHC) New Tie-Up to Boost Patient Outcomes
https://www.zacks.com/stock/news/2260545/ge-healthcare-s-gehc-new-tie-up-to-boost-patient-outcomes?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2260545
Apr 23, 2024 - GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.
0
Newmont's (NEM) Q1 Earnings and Revenues Beat Estimates
https://www.zacks.com/stock/news/2262672/newmont-s-nem-q1-earnings-and-revenues-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2262672
Apr 25, 2024 - Newmont's (NEM) first-quarter earnings and revenues exceed expectations, driven by increased production and higher realized gold prices.
0
Revvity's (RVTY) New Launch to Boost Tuberculosis Testing
https://www.zacks.com/stock/news/2262625/revvity-s-rvty-new-launch-to-boost-tuberculosis-testing?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2262625
Apr 25, 2024 - Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
0
Agnico Eagle's (AEM) Q1 Earnings and Sales Beat Estimates
https://www.zacks.com/stock/news/2263531/agnico-eagle-s-aem-q1-earnings-and-sales-beat-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2263531
Apr 26, 2024 - Agnico Eagle's (AEM) first-quarter earnings and revenues exceed expectations, driven by increased production and higher realized gold prices.
0
Factors Setting the Tone for Ecolab's (ECL) Q1 Earnings
https://www.zacks.com/stock/news/2263587/factors-setting-the-tone-for-ecolab-s-ecl-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2263587
Apr 26, 2024 - Ecolab's (ECL) first-quarter results are likely to reflect continued segmental strength.
0
Ecolab (ECL) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2225587/ecolab-ecl-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2225587
Feb 13, 2024 - While the top- and bottom-line numbers for Ecolab (ECL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Company News for Feb 14, 2024
https://www.zacks.com/stock/news/2226118/company-news-for-feb-14-2024?cid=CS-ZC-FT-corporate_summary-2226118
Feb 14, 2024 - Companies in The News Are: ZTS,MAR,ECL,HAS
0